Results 301 to 310 of about 359,480 (360)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acta Paediatrica, 2002
The aim of this study was to determine whether any relationship exists between the severity of mutation of the phenylalanine hydroxylase (PAH) gene and the plasma concentrations of phenylalanine (Phe) and tyrosine (Tyr) under fasting and semifasting conditions among heterozygotes in a matched case-control study.
E. Verduci +7 more
openaire +4 more sources
The aim of this study was to determine whether any relationship exists between the severity of mutation of the phenylalanine hydroxylase (PAH) gene and the plasma concentrations of phenylalanine (Phe) and tyrosine (Tyr) under fasting and semifasting conditions among heterozygotes in a matched case-control study.
E. Verduci +7 more
openaire +4 more sources
Phenylalanine Hydroxylase Activity
Archives of Pediatrics & Adolescent Medicine, 1983Sir .—In the article, "Diagnosis of Phenylalanine Hydroxylase Deficiency (Phenylketonuria)" (Journal1982;136:111-114), we are concerned by the recommendation of Berry and collegues that centers treating patients with phenylketonuria (PKU) should " . . .
D M, Danks, R G, Cotton
openaire +2 more sources
Phenylalanine hydroxylase deficiency
Genetics in Medicine, 2011Phenylalanine hydroxylase deficiency is an autosomal recessive disorder that results in intolerance to the dietary intake of the essential amino acid phenylalanine. It occurs in approximately 1:15,000 individuals. Deficiency of this enzyme produces a spectrum of disorders including classic phenylketonuria, mild phenylketonuria, and mild ...
John J, Mitchell +2 more
openaire +2 more sources
Activation of phenylalanine hydroxylase by phenylalanine
Biochimica et Biophysica Acta (BBA) - Enzymology, 1971Abstract 1. 1. Phenylalanine activates phenylalanine hydroxylase ( l -phenylalanine, tetrahydropteridine:oxygen oxidoreductase (4-hydroxylating), EC 1.14.3.1), when dithiothreitol is used to regenerate 2-amino-4-hydroxy-6,7-dimethyltetrahydropteridine. 2. 2.
openaire +2 more sources
Phenylalanine supplementation improves the phenylalanine profile in tyrosinaemia
Journal of Inherited Metabolic Disease, 2000AbstractTyrosinaemia types I and II are caused by enzyme deficiencies in the tyrosine catabolism pathway. Successful treatment is possible with the novel enzyme inhibitor NTBC in tyrosinaemia type I and with dietary tyrosine and phenylalanine restriction in both conditions.
C J, Wilson +3 more
openaire +2 more sources
Phenylalanine deficiency syndrome
The Journal of Pediatrics, 1966Clinical observations are recorded on two infants in whom failure to gain, eczema and listlessness developed during severe dietary restriction of phenylalanine. Regular diet was resumed when they were found not to have phenylketonuria; in spite of improvement in their nutritional status, their developmental progress remained slow.
openaire +2 more sources
Determination of p-halogenated phenylalanines and phenylalanine in plasma
Analytical Biochemistry, 1971Abstract A method for the determination, either in combination or singularly, for phenylalanine or some p -halogenated phenylalanines in blood plasma is presented. A thin-layer chromatographic procedure was elaborated which separates the p -halogenated phenylalanines from phenylalanine by means of a cation-exchange resin.
openaire +2 more sources
Molecular Genetics and Metabolism, 2007
BH(4) administration results in the reduction of blood phenylalanine level in patients with tetrahydrobiopterin (BH(4))-responsive phenylalanine hydroxylase (PAH) deficiency. The mechanism underlying BH(4) response remains unknown. Here, we studied the effects of BH(4) and phenylalanine on in vivo PAH activity of normal controls using the phenylalanine
Yoshiyuki, Okano +6 more
openaire +2 more sources
BH(4) administration results in the reduction of blood phenylalanine level in patients with tetrahydrobiopterin (BH(4))-responsive phenylalanine hydroxylase (PAH) deficiency. The mechanism underlying BH(4) response remains unknown. Here, we studied the effects of BH(4) and phenylalanine on in vivo PAH activity of normal controls using the phenylalanine
Yoshiyuki, Okano +6 more
openaire +2 more sources
Bulletin des Sociétés Chimiques Belges, 1974
Abstract(3‐(3‐Bromo‐4‐hydroxy‐S‐methoxy‐phenyl)alanine (Ie) exerts a long‐acting antihypertensive effect in rats and dogs : its synthesis and its optical resolution have already appeared in the literature. 1 Ten new mono‐ and polybrominated phenylalanines with hydroxy‐ and/or methoxy‐groups are here described.
M. L. Anhoury +3 more
openaire +1 more source
Abstract(3‐(3‐Bromo‐4‐hydroxy‐S‐methoxy‐phenyl)alanine (Ie) exerts a long‐acting antihypertensive effect in rats and dogs : its synthesis and its optical resolution have already appeared in the literature. 1 Ten new mono‐ and polybrominated phenylalanines with hydroxy‐ and/or methoxy‐groups are here described.
M. L. Anhoury +3 more
openaire +1 more source

